Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 58.12

+0.9%

10:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ian@SI who wrote (5953)	3/19/2002 4:08:09 PM
From: Biomaven	Read Replies (4) of 52153

Ian, <VPHM> Well no real surprise they got turned down - I don't think anyone I know was playing this on the bullish side. I tried some complicated options stuff on this one - my guess is I'll come out a little ahead, but likely not enough to be worth the hassle. Too bad about the drug, though. To my mind it works, and the main problem was the type of studies they did. I think they should have gone after people who are prone to complications (sinus, middle ear, bronchitis) after colds and tried to get approval in a much narrower indication. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next